Functional KCa3.1 channels regulate steroid insensitivity in bronchial smooth muscle cells

Journal of Immunology

Volumn 191, Issue 5, 2013, Pages 2624-2636

  Chachi, Latifa ^a   Shikotra, Aarti ^a   Duffy, S Mark ^a   Tliba, Omar ^b   Brightling, Christopher ^a   Bradding, Peter ^a   Amrani, Yassine ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; EOTAXIN; FLUTICASONE; FRACTALKINE; GAMMA INTERFERON; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR ALPHA; MESSENGER RNA; PHOSPHATASE; POTASSIUM CHANNEL; PROTEIN KCA 3.1; RANTES; SERINE THREONINE PROTEIN PHOSPHATASE 5; SHORT HAIRPIN RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; INTERMEDIATE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; KCNN4 PROTEIN, HUMAN;

ADULT; ARTICLE; ASTHMA; BRONCHUS BIOPSY; BRONCHUS MUSCLE; CCL11 GENE; CCL5 GENE; CELL MEMBRANE; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CX3CL1 GENE; DISEASE SEVERITY; DRUG MECHANISM; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE FIBER; BRONCHUS; CELL CULTURE; DRUG RESISTANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; PATCH CLAMP; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADULT; ASTHMA; BLOTTING, WESTERN; BRONCHI; CELLS, CULTURED; DRUG RESISTANCE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GLUCOCORTICOIDS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MALE; MYOCYTES, SMOOTH MUSCLE; PATCH-CLAMP TECHNIQUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84883336417     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300104     Document Type: Article

References (66)

1. American Thoracic Society. 2000. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. Am. J. Respir. Crit. Care Med. 162: 2341-2351.
2. Bhavsar, P., M. Hew, N. Khorasani, A. Torrego, P. J. Barnes, I. Adcock, and K. F. Chung. 2008. Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma. Thorax 63: 784-790.
3. Irusen, E., J. G. Matthews, A. Takahashi, P. J. Barnes, K. F. Chung, and I. M. Adcock. 2002. p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. J. Allergy Clin. Immunol. 109: 649-657.
4. Kam, J. C., S. J. Szefler, W. Surs, E. R. Sher, and D. Y. Leung. 1993. Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J. Immunol. 151: 3460-3466.
5. Leung, D. Y., Q. Hamid, A. Vottero, S. J. Szefler, W. Surs, E. Minshall, G. P. Chrousos, and D. J. Klemm. 1997. Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor beta. J. Exp. Med. 186: 1567-1574.
6. Matthews, J. G., K. Ito, P. J. Barnes, and I. M. Adcock. 2004. Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patients. J. Allergy Clin. Immunol. 113: 1100-1108.
7. Brightling, C. E., S. Gupta, F. Hollins, A. Sutcliffe, and Y. Amrani. 2011. Immunopathogenesis of severe asthma. Curr. Pharm. Des. 17: 667-673.
8. Cox, G., J. D. Miller, A. McWilliams, J. M. Fitzgerald, and S. Lam. 2006. Bronchial thermoplasty for asthma. Am. J. Respir. Crit. Care Med. 173: 965-969.
9. Cox, G., N. C. Thomson, A. S. Rubin, R. M. Niven, P. A. Corris, H. C. Siersted, R. Olivenstein, I. D. Pavord, D. McCormack, R. Chaudhuri, et al; AIR Trial Study Group. 2007. Asthma control during the year after bronchial thermoplasty. N. Engl. J. Med. 356: 1327-1337.
10. Danek, C. J., C. M. Lombard, D. L. Dungworth, P. G. Cox, J. D. Miller, M. J. Biggs, T. M. Keast, B. E. Loomas, W. J. Wizeman, J. C. Hogg, and A. R. Leff. 2004. Reduction in airway hyperresponsiveness to methacholine by the application of RF energy in dogs. J. Appl. Physiol. 97: 1946-1953.
11. Pavord, I. D., G. Cox, N. C. Thomson, A. S. Rubin, P. A. Corris, R. M. Niven, K. F. Chung, and M. Laviolette; RISA Trial Study Group. 2007. Safety and efficacy of bronchial thermoplasty in symptomatic, severe asthma. Am. J. Respir. Crit. Care Med. 176: 1185-1191.
12. Tliba, O., and Y. Amrani. 2008. Airway smooth muscle cell as an inflammatory cell: lessons learned from interferon signaling pathways. Proc. Am. Thorac. Soc. 5: 106-112.
13. El-Shazly, A., P. Berger, P. O. Girodet, O. Ousova, M. Fayon, J. M. Vernejoux, R. Marthan, and J. M. Tunon-de-Lara. 2006. Fraktalkine produced by airway smooth muscle cells contributes to mast cell recruitment in asthma. J. Immunol. 176: 1860-1868.
14. Ghaffar, O., Q. Hamid, P. M. Renzi, Z. Allakhverdi, S. Molet, J. C. Hogg, S. A. Shore, A. D. Luster, and B. Lamkhioued. 1999. Constitutive and cytokinestimulated expression of eotaxin by human airway smooth muscle cells. Am. J. Respir. Crit. Care Med. 159: 1933-1942.
15. Joubert, P., S. Lajoie-Kadoch, V. Wellemans, S. Letuve, M. K. Tulic, A. J. Halayko, and Q. Hamid. 2012. Expression and regulation of CCL15 by human airway smooth muscle cells. Clin. Exp. Allergy 42: 85-94.
16. Kaur, D., R. Saunders, P. Berger, S. Siddiqui, L. Woodman, A. Wardlaw, P. Bradding, and C. E. Brightling. 2006. Airway smooth muscle and mast cellderived CC chemokine ligand 19 mediate airway smooth muscle migration in asthma. Am. J. Respir. Crit. Care Med. 174: 1179-1188.
17. Foley, S. C., A. K. Mogas, R. Olivenstein, P. O. Fiset, J. Chakir, J. Bourbeau, P. Ernst, C. Lemière, J. G. Martin, and Q. Hamid. 2007. Increased expression of ADAM33 and ADAM8 with disease progression in asthma. J. Allergy Clin. Immunol. 119: 863-871.
18. Lee, J. Y., S. W. Park, H. K. Chang, H. Y. Kim, T. Rhim, J. H. Lee, A. S. Jang, E. S. Koh, and C. S. Park. 2006. A disintegrin and metalloproteinase 33 protein in patients with asthma: relevance to airflow limitation. Am. J. Respir. Crit. Care Med. 173: 729-735.
19. Wulff, H., and N. A. Castle. 2010. Therapeutic potential of KCa3.1 blockers: recent advances and promising trends. Expert Rev. Clin. Pharmacol. 3: 385-396.
20. Shepherd, M. C., S. M. Duffy, T. Harris, G. Cruse, M. Schuliga, C. E. Brightling, C. B. Neylon, P. Bradding, and A. G. Stewart. 2007. KCa3.1 Ca2+ activated K+ channels regulate human airway smooth muscle proliferation. Am. J. Respir. Cell Mol. Biol. 37: 525-531.
21. Toyama, K., H. Wulff, K. G. Chandy, P. Azam, G. Raman, T. Saito, Y. Fujiwara, D. L. Mattson, S. Das, J. E. Melvin, et al. 2008. The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans. J. Clin. Invest. 118: 3025-3037.
22. Kaushal, V., P. D. Koeberle, Y. Wang, and L. C. Schlichter. 2007. The Ca2+-activated K+ channel KCNN4/KCa3.1 contributes to microglia activation and nitric oxide-dependent neurodegeneration. J. Neurosci. 27: 234-244.
23. Reich, E. P., L. Cui, L. Yang, C. Pugliese-Sivo, A. Golovko, M. Petro, G. Vassileva, I. Chu, A. A. Nomeir, L. K. Zhang, et al. 2005. Blocking ion channel KCNN4 alleviates the symptoms of experimental autoimmune encephalomyelitis in mice. Eur. J. Immunol. 35: 1027-1036.
24. Tharp, D. L., B. R. Wamhoff, H. Wulff, G. Raman, A. Cheong, and D. K. Bowles. 2008. Local delivery of the KCa3.1 blocker, TRAM-34, prevents acute angioplasty-induced coronary smooth muscle phenotypic modulation and limits stenosis. Arterioscler. Thromb. Vasc. Biol. 28: 1084-1089.
25. Girodet, P. O., A. Ozier, G. Carvalho, O. Ilina, O. Ousova, A. P. Gadeau, H. Begueret, H. Wulff, R. Marthan, P. Bradding, and P. Berger. 2013. Ca(2+)-activated K(+) channel-3.1 blocker TRAM-34 attenuates airway remodeling and eosinophilia in a murine asthma model. Am. J. Respir. Cell. Mol. Biol. 48: 212-219.
26. Cruse, G., S. M. Duffy, C. E. Brightling, and P. Bradding. 2006. Functional KCa3.1 K+ channels are required for human lung mast cell migration. Thorax 61: 880-885.
27. Duffy, S. M., G. Cruse, C. E. Brightling, and P. Bradding. 2007. Adenosine closes the K+ channel KCa3.1 in human lung mast cells and inhibits their migration via the adenosine A2A receptor. Eur. J. Immunol. 37: 1653-1662.
28. Duffy, S. M., G. Cruse, W. J. Lawley, and P. Bradding. 2005. Beta2-adrenoceptor regulation of the K+ channel iKCa1 in human mast cells. FASEB J. 19: 1006-1008.
29. Duffy, S. M., M. L. Leyland, E. C. Conley, and P. Bradding. 2001. Voltagedependent and calcium-activated ion channels in the human mast cell line HMC- J. Leukoc. Biol. 70: 233-240.
30. Cruse, G., S. R. Singh, S. M. Duffy, C. Doe, R. Saunders, C. E. Brightling, and P. Bradding. 2011. Functional KCa3.1 K+ channels are required for human fibrocyte migration. J. Allergy Clin. Immunol. 128: 1303-1309.
31. Shao, Z., T. O. Makinde, and D. K. Agrawal. 2011. Calcium-activated potassium channel KCa3.1 in lung dendritic cell migration. Am. J. Respir. Cell Mol. Biol. 45: 962-968.
32. Shikotra, A., D. F. Choy, C. M. Ohri, E. Doran, C. Butler, B. Hargadon, M. Shelley, A. R. Abbas, C. D. Austin, J. Jackman, L. C. Wu, L. G. Heaney, J. R. Arron, and P. Bradding. 2012. Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma. J. Allergy Clin. Immunol. 129: 104-111.
33. British Thoracic Society Scottish Intercollegiate Guidelines Network. 2008. British Guideline on the Management of Asthma. Thorax 63(Suppl 4): iv1-iv121.
34. British Thoracic Society Bronchoscopy Guidelines Committee, a Subcommittee of Standards of Care Committee of British Thoracic Society. 2001. British Thoracic Society guidelines on diagnostic flexible bronchoscopy. Thorax 56 (Suppl 1): i1-i21.
35. Bradding, P., J. A. Roberts, K. M. Britten, S. Montefort, R. Djukanovic, R. Mueller, C. H. Heusser, P. H. Howarth, and S. T. Holgate. 1994. Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am. J. Respir. Cell Mol. Biol. 10: 471-480.
36. Brightling, C. E., A. J. Ammit, D. Kaur, J. L. Black, A. J. Wardlaw, J. M. Hughes, and P. Bradding. 2005. The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. Am. J. Respir. Crit. Care Med. 171: 1103-1108.
37. Chen, M. X., S. A. Gorman, B. Benson, K. Singh, J. P. Hieble, M. C. Michel, S. N. Tate, and D. J. Trezise. 2004. Small and intermediate conductance Ca(2 +)-activated K+ channels confer distinctive patterns of distribution in human tissues and differential cellular localisation in the colon and corpus cavernosum. Naunyn Schmiedebergs Arch. Pharmacol. 369: 602-615.
38. Wulff, H., M. J. Miller, W. Hansel, S. Grissmer, M. D. Cahalan, and K. G. Chandy. 2000. Design of a potent and selective inhibitor of the intermediateconductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant. Proc. Natl. Acad. Sci. USA 97: 8151-8156.
39. Stocker, J. W., L. De Franceschi, G. A. McNaughton-Smith, R. Corrocher, Y. Beuzard, and C. Brugnara. 2003. ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice. Blood 101: 2412-2418.
40. Amrani, Y., R. A. Panettieri, Jr., N. Frossard, and C. Bronner. 1996. Activation of the TNF alpha-p55 receptor induces myocyte proliferation and modulates agonist-evoked calcium transients in cultured human tracheal smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 15: 55-63.
41. Amrani, Y., A. L. Lazaar, and R. A. Panettieri, Jr. 1999. Up-regulation of ICAM-1 by cytokines in human tracheal smooth muscle cells involves an NF-kappa Bdependent signaling pathway that is only partially sensitive to dexamethasone. J. Immunol. 163: 2128-2134.
42. Schmittgen, T. D., and K. J. Livak. 2008. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3: 1101-1108.
43. Bouazza, B., K. Krytska, M. Debba-Pavard, Y. Amrani, R. E. Honkanen, J. Tran, and O. Tliba. 2012. Cytokines alter glucocorticoid receptor phosphorylation in airway cells: role of phosphatases. Am. J. Respir. Cell Mol. Biol. 47: 464-473.
44. Bhavsar, P., T. Ahmad, and I. M. Adcock. 2008. The role of histone deacetylases in asthma and allergic diseases. J. Allergy Clin. Immunol. 121: 580-584.
45. Zoratti, M., U. De Marchi, E. Gulbins, and I. Szabò. 2009. Novel channels of the inner mitochondrial membrane. Biochim. Biophys. Acta 1787: 351-363.
46. Ohya, S., S. Niwa, Y. Kojima, S. Sasaki, M. Sakuragi, K. Kohri, and Y. Imaizumi. 2011. Intermediate-conductance Ca2+-activated K+ channel, KCa3.1, as a novel therapeutic target for benign prostatic hyperplasia. J. Pharmacol. Exp. Ther. 338: 528-536.
47. Tliba, O., G. Damera, A. Banerjee, S. Gu, H. Baidouri, S. Keslacy, and Y. Amrani. 2008. Cytokines induce an early steroid resistance in airway smooth muscle cells: novel role of interferon regulatory factor-1. Am. J. Respir. Cell Mol. Biol. 38: 463-472.
48. Adcock, I. M., J. Marwick, P. Casolari, M. Contoli, K. F. Chung, P. Kirkham, A. Papi, and G. Caramori. 2010. Mechanisms of corticosteroid resistance in severe asthma and chronic obstructive pulmonary disease (COPD). Curr. Pharm. Des. 16: 3554-3573.
49. Durham, A., I. M. Adcock, and O. Tliba. 2011. Steroid resistance in severe asthma: current mechanisms and future treatment. Curr. Pharm. Des. 17: 674-684.
50. Bhandare, R., G. Damera, A. Banerjee, J. R. Flammer, S. Keslacy, I. Rogatsky, R. A. Panettieri, Y. Amrani, and O. Tliba. 2010. Glucocorticoid receptor interacting protein-1 restores glucocorticoid responsiveness in steroid-resistant airway structural cells. Am. J. Respir. Cell Mol. Biol. 42: 9-15.
51. Tliba, O., J. A. Cidlowski, and Y. Amrani. 2006. CD38 expression is insensitive to steroid action in cells treated with tumor necrosis factor-alpha and interferongamma by a mechanism involving the up-regulation of the glucocorticoid receptor beta isoform. Mol. Pharmacol. 69: 588-596.
52. Casola, A., A. Henderson, T. Liu, R. P. Garofalo, and A. R. Brasier. 2002. Regulation of RANTES promoter activation in alveolar epithelial cells after cytokine stimulation. Am. J. Physiol. Lung Cell. Mol. Physiol. 283: L1280-L1290.
53. John, M., S. J. Hirst, P. J. Jose, A. Robichaud, N. Berkman, C. Witt, C. H. Twort, P. J. Barnes, and K. F. Chung. 1997. Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines: regulation by T helper 2 cytokines and corticosteroids. J. Immunol. 158: 1841-1847.
54. Klein, H., L. Garneau, N. T. Trinh, A. Privé, F. Dionne, E. Goupil, D. Thuringer, L. Parent, E. Brochiero, and R. Sauvé. 2009. Inhibition of the KCa3.1 channels by AMP-activated protein kinase in human airway epithelial cells. Am. J. Physiol. Cell Physiol. 296: C285-C295.
55. Srivastava, S., O. Zhdanova, L. Di, Z. Li, M. Albaqumi, H. Wulff, and E. Y. Skolnik. 2008. Protein histidine phosphatase 1 negatively regulates CD4 T cells by inhibiting the K+ channel KCa3.1. Proc. Natl. Acad. Sci. USA 105: 14442-14446.
56. Srivastava, S., Z. Li, K. Ko, P. Choudhury, M. Albaqumi, A. K. Johnson, Y. Yan, J. M. Backer, D. Unutmaz, W. A. Coetzee, and E. Y. Skolnik. 2006. Histidine phosphorylation of the potassium channel KCa3.1 by nucleoside diphosphate kinase B is required for activation of KCa3.1 and CD4 T cells. Mol. Cell 24: 665-675.
57. Beeton, C., J. Barbaria, P. Giraud, J. Devaux, A. M. Benoliel, M. Gola, J. M. Sabatier, D. Bernard, M. Crest, and E. Béraud. 2001. Selective blocking of voltage-gated K+ channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation. J. Immunol. 166: 936-944.
58. Beeton, C., H. Wulff, J. Barbaria, O. Clot-Faybesse, M. Pennington, D. Bernard, M. D. Cahalan, K. G. Chandy, and E. Béraud. 2001. Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. Proc. Natl. Acad. Sci. USA 98: 13942-13947.
59. Di, L., S. Srivastava, O. Zhdanova, Y. Ding, Z. Li, H. Wulff, M. Lafaille, and E. Y. Skolnik. 2010. Inhibition of the K+ channel KCa3.1 ameliorates T cellmediated colitis. Proc. Natl. Acad. Sci. USA 107: 1541-1546.
60. Deshpande, D. A., S. Dogan, T. F.Walseth, S. M. Miller, Y. Amrani, J. Panettieri, A. Reynold, and M. S. Kannan. 2004. Modulation of calcium signaling by interleukin-13 in human airway smooth muscle: role of CD38/cyclic adenosine diphosphate ribose pathway. Am. J. Respir. Cell Mol. Biol. 31: -36-42.
61. Deshpande, D. A., T. F. Walseth, R. A. Panettieri, and M. S. Kannan. 2003. CD38-cyclic ADP-ribose-mediated Ca2+ signaling contributes to airway smooth muscle hyperresponsiveness. FASEB J. 17: 452-454.
62. White, T. A., A. Xue, E. N. Chini, M. Thompson, G. C. Sieck, and M. E. Wylam. 2006. Role of transient receptor potential C3 in TNF-alpha-enhanced calcium influx in human airway myocytes. Am. J. Respir. Cell Mol. Biol. 35: 243-251.
63. Clark, A. R., and M. G. Belvisi. 2012. Maps and legends: the quest for dissociated ligands of the glucocorticoid receptor. Pharmacol. Ther. 134: 54-67.
64. King, E. M., J. E. Chivers, C. F. Rider, A. Minnich, M. A. Giembycz, and R. Newton. 2013. Glucocorticoid repression of inflammatory gene expression shows differential responsiveness by transactivation- and transrepressiondependent mechanisms. PLoS ONE 8: e53936.
65. Ismaili, N., and M. J. Garabedian. 2004. Modulation of glucocorticoid receptor function via phosphorylation. Ann. N. Y. Acad. Sci. 1024: 86-101.
66. Zhang, Y., D. Y. Leung, S. K. Nordeen, and E. Goleva. 2009. Estrogen inhibits glucocorticoid action via protein phosphatase 5 (PP5)-mediated glucocorticoid receptor dephosphorylation. J. Biol. Chem. 284: 24542-24552.